SLC7A5 and lung cancer: Apart from the findings in lung cancer, a recent report showed that triggering naïve T cells via antigen receptors increases SLC7A5 expression and bioavailability of Met and results in increased levels of H3K4me3 and H3K27me3 in vitro and in vivo.